Inari Medical Inc
NASDAQ:NARI

Watchlist Manager
Inari Medical Inc Logo
Inari Medical Inc
NASDAQ:NARI
Watchlist
Price: 79.97 USD Market Closed
Market Cap: 4.7B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+52%
Revenue
Forecast
+2%
Operating Income
Forecast
+11%
Net Income
Forecast
N/A

Wall Street
Price Targets

NARI Price Targets Summary
Inari Medical Inc

Wall Street analysts forecast NARI stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NARI is 75.58 USD with a low forecast of 68.88 USD and a high forecast of 84 USD.

NARI Lowest Forecast
Wall Street Target
68.88 USD
14% Downside
NARI Average Forecast
Wall Street Target
75.58 USD
5% Downside
NARI Highest Forecast
Wall Street Target
84 USD
5% Upside
Lowest
Price Target
68.88 USD
14% Downside
Average
Price Target
75.58 USD
5% Downside
Highest
Price Target
84 USD
5% Upside
Inari Medical Inc Competitors:
Price Targets
CTSO
Cytosorbents Corp
614% Upside
V
100120
Vieworks Co Ltd
24% Upside
M
MYO
Myomo Inc
89% Upside
EMBLA
Embla Medical hf
47% Upside
CTSO
Cytosorbents Corp
614% Upside
V
100120
Vieworks Co Ltd
24% Upside
M
MYO
Myomo Inc
89% Upside
EMBLA
Embla Medical hf
47% Upside
NPCE
Neuropace Inc
41% Upside
ZBH
Zimmer Biomet Holdings Inc
10% Upside
S
688351
Shanghai MicroPort EP Medtech Co Ltd
60% Upside
300298
Sinocare Inc
47% Upside

Revenue
Forecast

Revenue Estimate
Inari Medical Inc

For the last 4 years the compound annual growth rate for Inari Medical Inc's revenue is 76%. The projected CAGR for the next 4 years is 19%.

76%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Inari Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Inari Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

See Also

Summary
NARI intrinsic value, competitors valuation, and company profile.
DCF Valuation
NARI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NARI stock valuation using valuation multiples.
Wall Street Estimates
NARI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NARI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NARI's stock price target?
Price Target
75.58 USD

According to Wall Street analysts, the average 1-year price target for NARI is 75.58 USD with a low forecast of 68.88 USD and a high forecast of 84 USD.

What is Inari Medical Inc's Revenue forecast?
Projected CAGR
19%

For the last 4 years the compound annual growth rate for Inari Medical Inc's revenue is 76%. The projected CAGR for the next 4 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.